Skip to content
Home/Companies/HealthTech/Inivata
Inivata

Inivata

HealthTech·UK·Exited 2021·Held under 1yr
Entry
2021
Hold
<1yr
Exit
2021

Who owns Inivata?

Inivata was owned by Rosetta Capital through Rosetta Capital V (2021 vintage) from 2021 to 2021, exited via Trade Sale. Across its history, Inivata has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-05-29

Rosetta Capital
Most recent investor
Rosetta Capital
Rosetta Capital V · 2021 · Secondaries
2 ownership periods · full history below

Key facts

HQUK
SectorHealthTech
StatusAcquired
Websitewww.inivata.com

Ownership history

2 ownership periods

Exited
Last exited in 2021 to NeoGenomics.
Cambridge Innovation Capital
Cambridge Innovation CapitalExited 2021
2016 · 2021(5yr) · CIC Fund I · 2013 · VC
Trade Sale · to NeoGenomics
MOIC
–
Rosetta Capital
Rosetta CapitalExited 2021
2021 · 2021(<1yr) · Rosetta Capital V · 2021 · Secondaries
Trade Sale · to NeoGenomics
MOIC
–

More from Rosetta Capital V

Other portfolio companies in the same fund.

Carrick Therapeutics
Carrick Therapeutics
Active
BiotechIreland· 2021
Immunocore
Immunocore
Active
BiotechUK· 2021
Mereo BioPharma
Mereo BioPharma
Active
BiotechUK· 2021
Mission Therapeutics
Mission Therapeutics
Active
BiotechUK· 2021
PsiOxus Therapeutics
Active
BiotechUK· 2021
ReNeuron
ReNeuron
Active
BiotechUK· 2021

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue